Primary Care Weight Loss Injection Service

With effect from 27 February 2026, YHP will no longer be providing the above service across Humber and North Yorkshire. This follows a decision by the ICB not to commission this specific service beyond this date.

The ICB is required to procure a new contract for 2026/27 onwards; however, funding for this service has not yet been confirmed by NHS England. NHS England has advised that the ICB is unable to commence procurement until implementation funding has been formally agreed.

As a result, there will be a temporary pause in the service for any new patients entering the service from 27 February 2026. All existing patients, who are already enrolled on the service (by 27.02.26), will continue to be seen under the current service arrangements.

Once funding is confirmed by NHS England, the ICB will seek to establish longer-term commissioning arrangements for patients to access tirzepatide for overweight and obesity, as per the NHS interim commissioning position, following the correct procurement processes.

Any queries should be directed to the ICB: https://humberandnorthyorkshire.org.uk/contact-us/

Tirzepatide (brand name Mounjaro®) is a new medication recently recommended by the National Institute for Health and Care Excellence (NICE) for some adults living with obesity. This service will deem if a patient is eligible for treatment and will direct them on for treatment and wraparound care if eligible.

What is tirzepatide (Mounjaro®)?

  • It helps reduce hunger, increases feeling of fullness, and supports weight loss by helping you eat less and improving how your body uses food and controls blood sugar.

  • Tirzepatide is given as a weekly injection, which you can administer yourself.

  • Tirzepatide must be prescribed as part of a support programme, also known as wraparound care. This includes advice on healthy eating, physical activity, and lifestyle changes. You must agree to take part in this support in order to receive the medication.

Who is eligible for treatment?

To be eligible for treatment, all of the below must apply:

  • You must be aged 18 or over

  • Have a Body Mass Index (BMI) of 40 or more (or ≥ 37.5 for people with South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds)

  • You must have FOUR out of the FIVE diagnosed long-term conditions listed below:

    • Cardiovascular disease

    • Hypertension

    • Dyslipidaemia

    • Obstructive sleep apnoea

    • Type-2 diabetes

How do I get treatment?

To receive treatment you must be willing to agree to the below:

  • You agree for us to have access to your medical record

  • You are willing to travel to your first appointment

  • You understand that you need to provide appropriate identification at your first appointment

  • You agree to commit to a 9-month ‘wrap around care’ treatment plan which offers advice on lifestyle, diet and exercise. Further information on this can be found HERE.